156 related articles for article (PubMed ID: 4174931)
1. The long-acting thyroid stimulator: its role in Graves' disease.
McKenzie JM
Recent Prog Horm Res; 1967; 23():1-46. PubMed ID: 4174931
[No Abstract] [Full Text] [Related]
2. Experimental production of a thyroid-stimulating antithyroid antibody.
McKenzie JM
J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
[No Abstract] [Full Text] [Related]
3. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
Strumia E
Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
[No Abstract] [Full Text] [Related]
4. LATS in Graves' disease.
McKenzie JM; Zakarija M
Recent Prog Horm Res; 1976; 33():29-57. PubMed ID: 198858
[No Abstract] [Full Text] [Related]
5. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
Burke G
J Clin Endocrinol Metab; 1967 Aug; 27(8):1095-102. PubMed ID: 4166580
[No Abstract] [Full Text] [Related]
6. The long-acting thyroid stimulator and thyroid disease.
Kriss JP
Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
[No Abstract] [Full Text] [Related]
7. [Etiology of Basedow's disease, with special reference to LATS].
Nagata K
Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
[No Abstract] [Full Text] [Related]
8. Mechanisms of Graves' disease and endocrine exophthalmos.
Anderson DR
Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
[No Abstract] [Full Text] [Related]
9. Pathogenesis of neonatal Graves' disease.
McKenzie JM; Zakarija M
J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
[No Abstract] [Full Text] [Related]
10. Endocrine exophthalmos: an immunologic aberration.
Kaplan HJ
Ophthalmic Semin; 1977; 2(2):203-46. PubMed ID: 327376
[No Abstract] [Full Text] [Related]
11. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
[No Abstract] [Full Text] [Related]
12. The long-acting thyroid stimulator.
Munro DS
J R Coll Physicians Lond; 1972 Apr; 6(3):309-15. PubMed ID: 5066947
[No Abstract] [Full Text] [Related]
13. Thyroid gland in Graves' disease: victim or culprit?
Chopra IJ; Solomon DH; Johnson DE; Chopra U
Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
[No Abstract] [Full Text] [Related]
14. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
Furth ED; Dentinger M
Endocrinology; 1971 Jul; 89(1):310-5. PubMed ID: 4103749
[No Abstract] [Full Text] [Related]
15. LATS and Graves' disease.
Soloman DH; Chopra IJ
Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
[No Abstract] [Full Text] [Related]
16. Long acting thyroid stimulator of Graves's disease.
Ochi Y; De Groot LJ
N Engl J Med; 1968 Mar; 278(13):718-21. PubMed ID: 4170527
[No Abstract] [Full Text] [Related]
17. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
18. [Pathogenesis of Basedow's disease].
Wuttke H
Fortschr Med; 1978 Dec; 96(46):2325-8. PubMed ID: 581489
[TBL] [Abstract][Full Text] [Related]
19. The nature and significance of the long-acting thyroid stimulator.
Kriss J
Adv Metab Disord; 1968; 3():209-30. PubMed ID: 4178338
[No Abstract] [Full Text] [Related]
20. The long-acting thyroid stimulator of Graves' disease.
Burke G
Am J Med; 1968 Sep; 45(3):435-50. PubMed ID: 4876801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
